Mark Mulligan, MD explained that Zika needs better diagnostic tests, which he knows can take some time, but is hopeful something will come along in a reasonable time frame.
A new drug combo had good results in treatment-naïve women with HIV, researchers reported today at IDWeek 2016 in New Orleans, LA.
Recommendations that children with asthma not get live attenuated flu vaccine may not be necessary, researchers found.
At IDWeek 2016, Mark Mulligan, MD, Hope Clinic at Emory Vaccine Center discussed his team's recent projects studying the natural history of Zika infection and their Zika vaccine trial.
Deaths from measles can come through a complication known as SSPE, and it is more common than thought. It can occur years after measles infection, even in adults.
As the population gets older, there is more work being done to determine the cause of dementia and Alzheimer's disease and find treatments as well. A new protein could be a solid step in that direction.
An experimental biologic for treating drug-resistant HIV showed dramatic results in phase 3 trials, researchers report. It's called ibalizumab.
Concerns that high-risk men on pre-exposure prophylaxis (PrEP) for HIV would stop using condoms and start getting other sexually transmitted infections have been somewhat validated in a Boston clinic.
Transmitted HIV drug resistance is a growing problem. Researchers found 20% of treat-naive HIV patients in a rural Southern US community had such transmitted drug resistant strains of the virus.